Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for EUROFINS SCIENT (ERFSF : OTC)

• Company Description    Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. Number of Employees: 62,696

• Price / Volume Information    Yesterday's Closing Price: $70.85 Daily Weekly Monthly 20 Day Moving Average: 1,541 shares Shares Outstanding: 192.98 (millions) Market Capitalization: $13,672.70 (millions) Beta: 0.63 52 Week High: $74.41 52 Week Low: $46.36 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 5.20% -0.50% 12 Week 32.20% 10.91% Year To Date 35.07% 26.51%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 23 Val Fleuri - Luxembourg,N4 1526 LUX ph: 352-2618-5320 fax: 352-2618-5331 ir@eurofins.com http://www.eurofins.com

• General Corporate Information    Officers Gilles Martin - Chief Executive Officer and Chairman Yves-Lo?c Martin - Director Valerie Hanote - Director Stuart Anderson - Director Fereshteh Pouchantchi - Director Peer Information EUROFINS SCIENT (CHCR) EUROFINS SCIENT (ESRX) EUROFINS SCIENT (MYDP) EUROFINS SCIENT (COR) EUROFINS SCIENT (GBCS) EUROFINS SCIENT (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: L31839134 SIC: 8880 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: 07/03/25 Share - Related Items Shares Outstanding: 192.98 Most Recent Split Date: 11.00 (10.00:1) Beta: 0.63 Market Capitalization: $13,672.70 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $3.93 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/03/25

• Fundamental Ratios P/E Current FY Estimate: 18.03 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.35 Price/Cash Flow: 9.83 Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 1.16 Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 1.09 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - 7.98 Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - 30.19 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - 38.87 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - 0.58 Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - 36.77

Powered by Zacks Investment Research ©